TY  - JOUR
PY  - 2020//
TI  - An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
JO  - Internal medicine
A1  - Hosoda, Tomohiro
A1  - Uehara, Yuki
A1  - Naito, Toshio
SP  - 285
EP  - 287
VL  - 59
IS  - 2
N2  - Patients with HIV infection represent a high-risk group for medication overdose because of the high frequency of complicating psychiatric disorders. Raltegravir is well-known for its low frequency of adverse effects. We herein report a 42-year-old Japanese man with HIV infection who was hospitalized 6 hours after overdosing with 24,000 mg of raltegravir in a suicide attempt. No serious adverse events occurred, although the plasma concentration of raltegravir at 18 hours after the overdose was 79,871.1 ng/mL. Raltegravir may be well-indicated for HIV patients at risk of overdosing.<p /> <p>Language: en</p>
LA  - en
SN  - 0918-2918
UR  - http://dx.doi.org/10.2169/internalmedicine.3498-19
ID  - ref1
ER  -